Tim Menzen

Dr. Tim Menzen is Chief Technology Officer of Coriolis Pharma, a science-driven contract research organization located in Munich, Germany for formulation development, lyophilization, and analytics of biopharmaceuticals). He is a pharmacist by training and received his PhD in the group of Prof. Dr. Wolfgang Frieß at the LMU in Munich, Germany. Tim received the Carl-Wilhelm-Scheele award of the German pharmaceutical society (DPhG) for the outstanding achievements during his PhD thesis. His research focused on temperature-induced unfolding, aggregation and interaction of mAbs, which resulted in three publications. In 2014, Tim joined Coriolis Pharma. He was leading formulation development projects for biologics for 3 years and was involved in the implementation of novel technologies. In his current role as CTO of Coriolis, he is involved in internal research projects at Coriolis and in scientific relations, including collaborations with partners from industry and academia. Tim is past chair of the AAPS Biopharmaceutical Product Attributes and Biological Consequences (PABC) Community.